News
Adobe is currently focused on user growth, and large-scale AI monetization may take more time to fully play out. Read more on ...
Adobe faces significant disruption risks from AI-first rivals, struggling to replicate their rapid revenue growth and AI ...
Adobe (ADBE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
StockStory.org on MSN4d
Why Adobe (ADBE) Shares Are Falling TodayShares of creative software maker Adobe (NASDAQ:ADBE) fell 5% in the afternoon session after the company reported ...
Live Updates Live Coverage Has Ended No Major News to Report from Adobe's Conference Call 6:13 pm by Adobe’s conference call has concluded and no major movements happened with the stock. Overall, it ...
The momentum allowed Adobe to raise its annual guidance, boosting revenue to $23.50 billion to $23.60 billion, up from the previous range of $23.30 billion to $23.55 billion. That is better than ...
RBC Capital reaffirmed its Outperform rating and $480.00 price target on Adobe (NASDAQ:ADBE) Friday, citing the company’s solid performance ... to InvestingPro analysis, Adobe appears ...
A diagnostic decision support system, or DDSS, outperformed generative AI when it came to diagnosing disease, a study ...
Adobe (NASDAQ:ADBE) reported Q2 FY2025 results on June 12, 2025, posting record revenue of $5.87 billion, up 11% year over year, non-GAAP EPS of $5.06, up 13% year over year, and raising FY2025 ...
StockStory.org on MSN18h
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The RestAs the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
StockStory.org on MSN8d
Spotting Winners: Adobe (NASDAQ:ADBE) And Design Software Stocks In Q1Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results